391 related articles for article (PubMed ID: 28401148)
1. New Insights into the Epigenetics of Hepatocellular Carcinoma.
Wahid B; Ali A; Rafique S; Idrees M
Biomed Res Int; 2017; 2017():1609575. PubMed ID: 28401148
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics in hepatocellular carcinoma.
Nagaraju GP; Dariya B; Kasa P; Peela S; El-Rayes BF
Semin Cancer Biol; 2022 Nov; 86(Pt 3):622-632. PubMed ID: 34324953
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives.
Ma L; Chua MS; Andrisani O; So S
World J Gastroenterol; 2014 Jan; 20(2):333-45. PubMed ID: 24574704
[TBL] [Abstract][Full Text] [Related]
4. The Epigenetic Regulation of HCC Metastasis.
Han TS; Ban HS; Hur K; Cho HS
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544763
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics of hepatocellular carcinoma: a new horizon.
Liu WR; Shi YH; Peng YF; Fan J
Chin Med J (Engl); 2012 Jul; 125(13):2349-60. PubMed ID: 22882861
[TBL] [Abstract][Full Text] [Related]
6. A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation.
Liu A; Wu Q; Peng D; Ares I; Anadón A; Lopez-Torres B; Martínez-Larrañaga MR; Wang X; Martínez MA
Med Res Rev; 2020 Sep; 40(5):1973-2018. PubMed ID: 32525219
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis.
Rongrui L; Na H; Zongfang L; Fanpu J; Shiwen J
Curr Pharm Des; 2014; 20(11):1715-25. PubMed ID: 23888939
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation mediated downregulation of histone H3 variant H3.3 affects cell proliferation contributing to the development of HCC.
Reddy D; Bhattacharya S; Shah S; Rashid M; Gupta S
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166284. PubMed ID: 34626773
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation in hepatocellular carcinoma.
Tischoff I; Tannapfe A
World J Gastroenterol; 2008 Mar; 14(11):1741-8. PubMed ID: 18350605
[TBL] [Abstract][Full Text] [Related]
11. LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating
Kang CL; Qi B; Cai QQ; Fu LS; Yang Y; Tang C; Zhu P; Chen QW; Pan J; Chen MH; Wu XZ
Theranostics; 2019; 9(15):4421-4436. PubMed ID: 31285770
[No Abstract] [Full Text] [Related]
12. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.
Pogribny IP; Rusyn I
Cancer Lett; 2014 Jan; 342(2):223-30. PubMed ID: 22306342
[TBL] [Abstract][Full Text] [Related]
13. The Role of Histone Acetylation-/Methylation-Mediated Apoptotic Gene Regulation in Hepatocellular Carcinoma.
Rajan PK; Udoh UA; Sanabria JD; Banerjee M; Smith G; Schade MS; Sanabria J; Sodhi K; Pierre S; Xie Z; Shapiro JI; Sanabria J
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255318
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.
Lin B; Zhou X; Lin S; Wang X; Zhang M; Cao B; Dong Y; Yang S; Wang JM; Guo M; Huang J
J Mol Med (Berl); 2017 Nov; 95(11):1237-1249. PubMed ID: 28844099
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?
Gnoni A; Santini D; Scartozzi M; Russo A; Licchetta A; Palmieri V; Lupo L; Faloppi L; Palasciano G; Memeo V; Angarano G; Brunetti O; Guarini A; Pisconti S; Lorusso V; Silvestris N
Expert Opin Ther Targets; 2015; 19(12):1623-35. PubMed ID: 26212068
[TBL] [Abstract][Full Text] [Related]
16. lncRNA DQ786243 promotes hepatocellular carcinoma cell invasion and proliferation by regulating the miR‑15b‑5p/Wnt3A axis.
Lin Z; Liu J
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760109
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation-mediated epigenetic regulation of oncogenic RPS2 as a novel therapeutic target and biomarker in hepatocellular carcinoma.
Abi Zamer B; Rah B; Jayakumar MN; Abumustafa W; Hamad M; Muhammad JS
Biochem Biophys Res Commun; 2024 Feb; 696():149453. PubMed ID: 38181486
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.
Herceg Z; Paliwal A
Mutat Res; 2011; 727(3):55-61. PubMed ID: 21514401
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.
Chappell G; Kutanzi K; Uehara T; Tryndyak V; Hong HH; Hoenerhoff M; Beland FA; Rusyn I; Pogribny IP
Int J Cancer; 2014 Jun; 134(12):2778-88. PubMed ID: 24242335
[TBL] [Abstract][Full Text] [Related]
20. LINC00978 promotes the progression of hepatocellular carcinoma by regulating EZH2-mediated silencing of p21 and E-cadherin expression.
Xu X; Gu J; Ding X; Ge G; Zang X; Ji R; Shao M; Mao Z; Zhang Y; Zhang J; Mao F; Qian H; Xu W; Cai H; Wang F; Zhang X
Cell Death Dis; 2019 Oct; 10(10):752. PubMed ID: 31582742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
